The New York Times, April 16, 2021 (with Noah Weiland)

Link

The White House on Friday announced an almost $2 billion plan for expanding and improving the nation’s ability to track coronavirus variants, an effort that public health experts have said is desperately needed to fight against variants that could drive another wave or potentially undermine the effectiveness of vaccines.

Continue reading “The White House details a nearly $2 billion plan to enhance the tracking of variants”

The New York Times, April 14, 2021 (with Denise Grady)

Link

The pause in the use of Johnson & Johnson’s Covid-19 vaccine may continue for a week to 10 days, after expert advisers to the Centers for Disease Control and Prevention determined on Wednesday that they needed more time to assess a possible link to a rare but serious blood-clotting disorder.

Continue reading “C.D.C. Panel Keeps Pause on Use of J&J Vaccine, Citing Need to Assess Potential Risks”

The New York Times, April 13, 2021 (with Denise Grady)

Link

On Tuesday morning, U.S. federal health regulators recommended a pause in the use of Johnson & Johnson’s Covid-19 vaccine while they investigated six reports of blood clots in women ages 18 to 48. One has died, and a second is hospitalized in critical condition.

Continue reading “J&J Vaccine and Blood Clots: The Risks, if Any, Are Very Low”

The New York Times, April 13, 2021 (with Noah Weiland and Sharon LaFraniere)

Link

Injections of Johnson & Johnson’s coronavirus vaccine came to a sudden halt across the country on Tuesday after federal health agencies called for a pause in the vaccine’s use as they examine a rare blood-clotting disorder that emerged in six recipients.

Continue reading “Johnson & Johnson Vaccinations Paused After Rare Clotting Cases Emerge”

The New York Times, April 9, 2021

Link

The prospect of a fourth wave of the coronavirus, with new cases climbing sharply in the Upper Midwest, has reignited a debate among vaccine experts over how long to wait between the first and second doses. Extending that period would swiftly increase the number of people with the partial protection of a single shot, but some experts fear it could also give rise to dangerous new variants.

Continue reading “To Speed Vaccination, Some Call for Delaying Second Shots”